Biocon share price has zoomed 4% and is presently trading at Rs 351.5.
Meanwhile, the BSE HEALTHCARE index is at 36,720.0 (down 0.1%).
Among the top gainers in the BSE HEALTHCARE index today are SUN PHARMA ADV. RES. (up 3.7%) and GRANULES INDIA (up 3.1%).
APOLLO HOSPITALS (down 2.5%) and HIKAL CHEMIC (down 2.2%) are among the top losers today.
Over the last one year, Biocon has moved up from Rs 240.0 to Rs 351.5, registering a gain of Rs 111.6 (up 46.5%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,266.1 to 36,720.0, registering a gain of 45.3% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Cadila Healthcare (up 90.3%), Glenmark Pharma (up 90.0%) and GSK Pharma (up 82.4%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 78,704.3 (up 0.8%).
The top gainers among the BSE Sensex today are Reliance Ind. (up 4.4%) and Bharti Airtel (up 3.2%). The most traded stocks in the BSE Sensex are Tata Steel and Reliance Ind..
In the meantime, NSE Nifty is at 23,877.2 (up 0.7%). Reliance Ind. and Bharti Airtel are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 62,970.0 to 78,704.3, registering a gain of 15,734.3 points (up 25.0%).
Biocon net profit fell 50.4% YoY to Rs 2,256 million for the quarter ended March 2024, compared to a profit of Rs 4,546 million a year ago. Net sales rose 3.8% to Rs 39,171 million during the period as against Rs 37,739 million in January-March 2023.
For the year ended March 2023, Biocon reported 16.7% decrease in net profit to Rs 6,430 million compared to net profit of Rs 7,716 million during FY22. Revenue of the company grew 36.5% to Rs 111,742 million during FY23.
The current Price to earnings ratio of Biocon, based on rolling 12 month earnings, stands at 30.5.
Equitymaster requests your view! Post a comment on "Biocon Gains 4%; BSE HEALTHCARE Index Down 0.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!